Multiple organ-specific autoantibodies in patients with phenotypic type 2 diabetes in China: a post-hoc analysis of the China National Diabetes and Metabolic Disorders Study

Yufei Xiang(Central South University), Zhiguang Zhou(Central South University), Tubao Yang(Central South University), Qiuhe Ji(Xijing Hospital), Linong Ji(Peking University), Jiapu Ge(People's Hospital of Xinjiang Uygur Autonomous Region), Yaxi Zhu(Central South University), Zhenqi Liu(University of Virginia Health System), Zhongyan Shan(First Hospital of China Medical University), Xuan Zuo(Central South University), Gan Huang(Central South University), Wenying Yang(China-Japan Friendship Hospital), Dalong Zhu(Unknown), Haoming Tian(Sichuan University), Li Chen(Shanghai East Hospital), Qiang Li(Wannan Medical College), Xia Li(Shanghai University), Xiaohui Guo(Peking University), Xinyuan Liu(Central South University), Zhigang Zhao(Hebei Medical University), Lixiang Lin(Fujian Provincial Hospital), Jie Liu(Stanford University), Juming Lu(Chinese PLA General Hospital), Weiping Jia(NovaBay Pharmaceuticals (United States)), Qiong Feng(Central South University), Jianping Weng(University of Science and Technology of China)
The Lancet Diabetes & Endocrinology
November 1, 2016
Cited by 0


Related Papers